Promotion of lymphatic function
US11992467B2 · kind B2 · utility
0Cited by
2References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 24, 2022 |
| Grant date | May 28, 2024 |
| Priority date | — |
| Expiry date | May 11, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention refers to lipophilic extracts of members of the Iridaceae family, such as Iris germanica and/or Iris pallida, that have been found to promote lymphatic function. These extracts are suitable for the treatment of skin inflammation, rheumatoid arthritis, impaired wound healing, chronic inflammatory diseases, chronic airway inflammation, inflammatory bowel disease, rosacea, primary and/or secondary lymphedemas. The most active components were found to be the iridals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.